X4 Pharmaceuticals, Inc

Industry: Biotechnology (See others in industry)

Address:
61 North Beacon Street 4 Th Floor
Boston, MA, 02134
Phone: 857-529-8300

Filings

Date Type Incremental Cash Raw Filing
2025-08-25 New Unknown SEC link
2023-06-01 New $65,015,462 SEC link
2022-07-19 New $55,749,999 SEC link
2017-12-04 New $20,000,000 SEC link
2017-05-08 New $45,539,314 SEC link
2016-04-27 New $15,007,220 SEC link
2015-12-30 New $4,000,000 SEC link
2015-06-05 Amended $7,000,001 SEC link
2014-08-11 Amended $0 SEC link
2013-08-13 New $12,999,999 SEC link
2011-02-07 New $9,600,002 SEC link
2010-09-24 New $400,002 SEC link

Directors and Executives (Current and Past)

Name Role
Jan Adams Director
William Aliski Director
Errik B Anderson Director, Executive
Christophe Arbet Engels Executive
Mark Baldry Executive
Robert L. Birnbaum Executive
Gary J. Bridger Director
Dan Burgess Director
Daniel Burgess Director
Diego Cadavid Executive
William Clark Director
Adam Craig Director, Executive
Francoise De Craecker Director
Mary Di Biase Executive
Tillman U. Gerngross Director
Carl Gordon Director
Michael Gray Executive
David Kirske Executive
Alison Lawton Director
David Mantus Executive
David Mc Girr Director
Terrance Mc Guire Director
Derek Meisner Executive
Adam Mostafa Executive
Eszter Nagy Executive
Claudio Nessi Director
Paula Ragan Director, Executive
Michael Ross Director
Rene Russo Director, Executive
Amy Schulman Director
Chris Stevens Executive
Murray W. Stewart Director
Arthur Taveras Executive
John Volpone Executive
Michael S. Wyzga Director